Pack Size | 10*10 Capsules |
Pack Type | Box |
Drug Composition | Rabeprazole Sodium 20 mg + Levosulride75 mg |
Brand Name | RABKOZOL-L |
Shelf Life | 24 Months |
Usage/Application | Treats gastroesophageal reflux disease and intestinal ulcers |
Prescription/Non-Prescription | Prescription |
Also Gives | PCD Pharma Franchise, Third Party Manufacturing |
Country of Origin | Made in India |
*Welcome to Rabkozol-L - Your Trusted Companion for Acid-Related Disorders!
*Product Overview:*- Brand Name: Rabkozol-L Tablets- Composition: Rabeprazole (20mg) + Levosulpiride (75mg)
*Key Features:*1. *Dual Action Formula:* Rabkozol-L combines the potent acid-suppressing action of Rabeprazole with the prokinetic effect of Levosulpiride, providing comprehensive relief from acid-related symptoms and associated gastric motility disorders.2. *Effective Acid Suppression:* Rabeprazole inhibits gastric acid secretion by blocking the proton pump in gastric parietal cells, reducing acidity and providing relief from heartburn, acid reflux, and related symptoms.3. *Prokinetic Effect:* Levosulpiride enhances gastrointestinal motility by increasing the release of acetylcholine, facilitating gastric emptying and relieving symptoms such as bloating, nausea, and early satiety.4. *Fast and Lasting Relief:* With rapid onset of action and sustained duration of effect, Rabkozol-L offers quick and lasting relief from acid-related symptoms, allowing patients to experience comfort and well-being throughout the day.
*Indications:*Rabkozol-L is indicated for the:- Treatment of gastroesophageal reflux disease (GERD)- Symptomatic relief of dyspepsia, heartburn, acid reflux, and regurgitation- Management of gastric motility disorders and associated symptoms
*Dosage and Administration:*- Adults: One tablet daily, preferably before meals, for up to 8 weeks or as directed by a healthcare professional.- Children: Safety and efficacy in pediatric patients have not been established.
*Precautions and Warnings:*- Hypersensitivity: Discontinue Rabkozol-L if signs of hypersensitivity reactions occur.- Cardiac effects: Use with caution in patients with underlying cardiac conditions or risk factors for QT prolongation.- Long-term use: Avoid prolonged therapy without regular monitoring for potential adverse effects.
*Adverse Reactions:*- Common adverse effects include headache, diarrhea, abdominal pain, nausea, and dizziness.- Rare but serious adverse reactions such as cardiac arrhythmias, extrapyramidal symptoms, and hyperprolactinemia may occur.
Pack Size | 10*10 Capsules |
Pack Type | Box |
Drug Composition | Rabeprazole Sodium 20 mg + Levosulride75 mg |
Brand Name | RABKOZOL-L |
Shelf Life | 24 Months |
Usage/Application | Treats gastroesophageal reflux disease and intestinal ulcers |
Prescription/Non-Prescription | Prescription |
Also Gives | PCD Pharma Franchise, Third Party Manufacturing |
Country of Origin | Made in India |
*Welcome to Rabkozol-L - Your Trusted Companion for Acid-Related Disorders!
*Product Overview:*- Brand Name: Rabkozol-L Tablets- Composition: Rabeprazole (20mg) + Levosulpiride (75mg)
*Key Features:*1. *Dual Action Formula:* Rabkozol-L combines the potent acid-suppressing action of Rabeprazole with the prokinetic effect of Levosulpiride, providing comprehensive relief from acid-related symptoms and associated gastric motility disorders.2. *Effective Acid Suppression:* Rabeprazole inhibits gastric acid secretion by blocking the proton pump in gastric parietal cells, reducing acidity and providing relief from heartburn, acid reflux, and related symptoms.3. *Prokinetic Effect:* Levosulpiride enhances gastrointestinal motility by increasing the release of acetylcholine, facilitating gastric emptying and relieving symptoms such as bloating, nausea, and early satiety.4. *Fast and Lasting Relief:* With rapid onset of action and sustained duration of effect, Rabkozol-L offers quick and lasting relief from acid-related symptoms, allowing patients to experience comfort and well-being throughout the day.
*Indications:*Rabkozol-L is indicated for the:- Treatment of gastroesophageal reflux disease (GERD)- Symptomatic relief of dyspepsia, heartburn, acid reflux, and regurgitation- Management of gastric motility disorders and associated symptoms
*Dosage and Administration:*- Adults: One tablet daily, preferably before meals, for up to 8 weeks or as directed by a healthcare professional.- Children: Safety and efficacy in pediatric patients have not been established.
*Precautions and Warnings:*- Hypersensitivity: Discontinue Rabkozol-L if signs of hypersensitivity reactions occur.- Cardiac effects: Use with caution in patients with underlying cardiac conditions or risk factors for QT prolongation.- Long-term use: Avoid prolonged therapy without regular monitoring for potential adverse effects.
*Adverse Reactions:*- Common adverse effects include headache, diarrhea, abdominal pain, nausea, and dizziness.- Rare but serious adverse reactions such as cardiac arrhythmias, extrapyramidal symptoms, and hyperprolactinemia may occur.